FDA extends review process for Novartis drug by three months
The review process for a drug to treat patients with relapsing multiple sclerosis was extended by three months.
Wednesday, June 3, 2020
FOX NEWS: FDA extends review process for Novartis drug by three months
FDA extends review process for Novartis drug by three months
The review process for a drug to treat patients with relapsing multiple sclerosis was extended by three months.
0 comments:
Post a Comment